SEC 13F Intelligence

Lion Point Capital, LP / MRNSUSD

Lion Point Capital, LP’s Marinus Pharmaceuticals Inc Position

Does Lion Point Capital, LP own Marinus Pharmaceuticals Inc (MRNSUSD)? Not currently — the last reported position was 10.87M shares worth $28M in Q2 2020; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$28M
Q2 2020
Shares
10.87M
% of Portfolio
+6.70%
Quarters Held
4
position exited

Position History MRNSUSD

Reported value by quarter
Q3 ’19: $5MQ3 ’19Q4 ’19: $14MQ4 ’19Q1 ’20: $13MQ1 ’20Q2 ’20: $28MQ2 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q2 202010.87M$28M+6.70%
Q1 20206.37M$13M+3.41%
Q4 20196.37M$14M+1.28%
Q3 20193.45M$5M+0.59%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Lion Point Capital, LP’s full portfolio or all institutional holders of MRNSUSD.